NAMPT and polycystic ovary syndrome: A recent meta-analysis revealed no statistically significant differences in serum resistin and visfatin levels between patients with PCOS and control women, although serum resistin and visfatin levels were higher among both obese and normal-weight patients with PCOS than in the controls [59].